In many cancers, including brain tumors, the efficacy of chemotherapy, radiation therapy, targeted immunotherapies, and oncolytic viruses depends on interferon (IFN) signaling for direct tumor-cell killing and/or to elicit indirect antitumor immune responses [10,11]. The gene discussed is IFNA1; the disease is brain neoplasm.